Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Adjuvant radiation for positive margins in adult head and neck sarcomas is associated with improved survival: Analysis of the National Cancer Database.

Cannon RB, Kull AJ, Carpenter PS, Francis S, Buchmann LO, Monroe MM, Lloyd S, Hitchcock YJ, Cannon D, Weis JR, Houlton JJ, Hunt JP.

Head Neck. 2019 Jan 16. doi: 10.1002/hed.25619. [Epub ahead of print]

PMID:
30652375
2.

Demographics, stage distribution, and relative roles of surgery and radiotherapy on survival of persons with primary prostate sarcomas.

Tward JD, Poppe MM, Hitchcock YJ, O'Neil B, Albertson DJ, Shrieve DC.

Cancer Med. 2018 Dec;7(12):6030-6039. doi: 10.1002/cam4.1872. Epub 2018 Nov 19.

3.

Adjuvant radiation for T1-2N1 oral cavity cancer survival outcomes and utilization treatment trends: Analysis of the SEER database.

Torrecillas V, Shepherd HM, Francis S, Buchmann LO, Monroe MM, Lloyd S, Cannon D, Hitchcock YJ, Weis JR, Hunt JP, Houlton JJ, Cannon RB.

Oral Oncol. 2018 Oct;85:1-7. doi: 10.1016/j.oraloncology.2018.07.019. Epub 2018 Aug 6.

PMID:
30220313
4.

Adjuvant therapy for resected pN2 non-small cell lung cancer: sequence is not all that matters.

Kokeny KE, Francis S, Tao R, Hitchcock YJ.

J Thorac Dis. 2018 Jun;10(Suppl 17):S2097-S2099. doi: 10.21037/jtd.2018.05.152. No abstract available.

5.

NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018.

Colevas AD, Yom SS, Pfister DG, Spencer S, Adelstein D, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Eisele DW, Fenton M, Foote RL, Gilbert J, Gillison ML, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Zhen W, Burns JL, Darlow SD.

J Natl Compr Canc Netw. 2018 May;16(5):479-490. doi: 10.6004/jnccn.2018.0026.

PMID:
29752322
6.

Academic Facility Utilization and Survival Outcomes in Adult Head and Neck Sarcomas: An NCDB Analysis.

Cannon RB, Carpenter PS, Boothe D, Buchmann LO, Hunt JP, Lloyd S, Hitchcock YJ, Houlton JJ, Weis JR, Shepherd HM, Monroe MM.

Otolaryngol Head Neck Surg. 2018 Sep;159(3):473-483. doi: 10.1177/0194599818768495. Epub 2018 Apr 17.

PMID:
29661049
7.

Esthesioneuroblastoma: A Patterns-of-Care and Outcomes Analysis of the National Cancer Database.

Orton A, Boothe D, Evans D, Lloyd S, Monroe MM, Jensen R, Shrieve DC, Hitchcock YJ.

Neurosurgery. 2018 Nov 1;83(5):940-947. doi: 10.1093/neuros/nyx535.

PMID:
29481629
8.

Radiotherapy regimens in patients with nonmelanoma head and neck skin cancers.

Dundar Y, Cannon RB, Hunt JP, Monroe M, Suneja G, Hitchcock YJ.

Int J Dermatol. 2018 Apr;57(4):441-448. doi: 10.1111/ijd.13879. Epub 2018 Jan 22.

PMID:
29355917
9.

Sequencing of Postoperative Radiotherapy and Chemotherapy for Locally Advanced or Incompletely Resected Non-Small-Cell Lung Cancer.

Francis S, Orton A, Stoddard G, Tao R, Hitchcock YJ, Akerley W, Kokeny KE.

J Clin Oncol. 2018 Feb 1;36(4):333-341. doi: 10.1200/JCO.2017.74.4771. Epub 2017 Dec 13.

PMID:
29236592
10.

The Benefit of Adjuvant Radiation in Surgically-Treated T1-2 N1 Oropharyngeal Squamous Cell Carcinoma.

Monroe MM, Buchmann LO, Hunt JP, Hitchcock YJ, Lloyd S, Hashibe M.

Laryngoscope Investig Otolaryngol. 2017 Feb 2;2(2):57-62. doi: 10.1002/lio2.64. eCollection 2017 Apr.

11.

Risk factors for development of melanoma brain metastasis and disease progression: a single-center retrospective analysis.

Gardner LJ, Ward M, Andtbacka RHI, Boucher KM, Bowen GM, Bowles TL, Cohen AL, Grossmann K, Hitchcock YJ, Holmen SL, Hyngstrom J, Khong H, McMahon M, Monroe MM, Ross CB, Suneja G, Wada D, Grossman D.

Melanoma Res. 2017 Oct;27(5):477-484. doi: 10.1097/CMR.0000000000000382.

12.

NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.

Adelstein D, Gillison ML, Pfister DG, Spencer S, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Gilbert J, Haddad RI, Hicks WL Jr, Hitchcock YJ, Jimeno A, Leizman D, Lydiatt WM, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Yom SS, Zhen W, Burns JL, Darlow SD.

J Natl Compr Canc Netw. 2017 Jun;15(6):761-770. doi: 10.6004/jnccn.2017.0101.

PMID:
28596256
13.

A Case of Complete Abscopal Response in High-Grade Pleiomorphic Sarcoma Treated with Radiotherapy Alone.

Orton A, Wright J, Buchmann L, Randall L, Hitchcock YJ.

Cureus. 2016 Oct 7;8(10):e821.

14.

Increasing use of nonsurgical therapy in advanced-stage oral cavity cancer: A population-based study.

Cannon RB, Sowder JC, Buchmann LO, Hunt JP, Hitchcock YJ, Lloyd S, Grossman KF, Monroe MM.

Head Neck. 2017 Jan;39(1):82-91. doi: 10.1002/hed.24542. Epub 2016 Sep 19.

PMID:
27641220
15.

Postoperative Radiotherapy in Locally Invasive Malignancies of the Thymus: Patterns of Care andĀ Survival.

Boothe D, Orton A, Thorpe C, Kokeny K, Hitchcock YJ.

J Thorac Oncol. 2016 Dec;11(12):2218-2226. doi: 10.1016/j.jtho.2016.07.032. Epub 2016 Aug 17.

16.

Paraneoplastic opsoclonus associated with squamous cell carcinoma of the tongue.

Wynn D, Merriman J, Patel AB, Hitchcock YJ, Garrido-Laguna I, Renner D, Clardy SL.

Clin Neurol Neurosurg. 2016 Oct;149:11-4. doi: 10.1016/j.clineuro.2016.05.023. Epub 2016 Jul 14. No abstract available.

PMID:
27450762
17.

The "decay" of brachytherapy use in tumors of the oral cavity: A population-based patterns of care and outcomes analysis from 1973 to 2012.

Orton A, Boothe D, Gan M, Monroe MM, Hitchcock YJ, Lloyd S.

Brachytherapy. 2016 Nov - Dec;15(6):851-858. doi: 10.1016/j.brachy.2016.05.007. Epub 2016 Jun 28.

PMID:
27364872
18.

Prognostic Model of Death and Distant Metastasis for Nasopharyngeal Carcinoma Patients Receiving 3DCRT/IMRT in Nonendemic Area of China.

Zang J, Li C, Zhao LN, Wang JH, Xu M, Luo SQ, Hitchcock YJ, Shi M.

Medicine (Baltimore). 2016 May;95(21):e3794. doi: 10.1097/MD.0000000000003794.

19.

Dosimetric evaluation of abdominal compression as a method to reduce the incidence of radiation-induced pneumonitis in lung SBRT treatment.

Sarkar V, Huang L, Huang YJ, Szegedi MW, Rassiah-Szegedi P, Zhao H, Hitchcock YJ, Kokeny KE, Wang B, Salter BJ.

J Radiosurg SBRT. 2016;4(2):125-132.

20.

Primary Pulmonary Carcinoid Tumor: A Long-term Single Institution Experience.

Herde RF, Kokeny KE, Reddy CB, Akerley WL, Hu N, Boltax JP, Hitchcock YJ.

Am J Clin Oncol. 2018 Jan;41(1):24-29. doi: 10.1097/COC.0000000000000221.

21.

Head and Neck Cancers, Version 1.2015.

Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Foote RL, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian N, Hughes M.

J Natl Compr Canc Netw. 2015 Jul;13(7):847-55; quiz 856.

22.

Significant Reduction of Late Toxicities in Patients With Extremity Sarcoma Treated With Image-Guided Radiation Therapy to a Reduced Target Volume: Results of Radiation Therapy Oncology Group RTOG-0630 Trial.

Wang D, Zhang Q, Eisenberg BL, Kane JM, Li XA, Lucas D, Petersen IA, DeLaney TF, Freeman CR, Finkelstein SE, Hitchcock YJ, Bedi M, Singh AK, Dundas G, Kirsch DG.

J Clin Oncol. 2015 Jul 10;33(20):2231-8. doi: 10.1200/JCO.2014.58.5828. Epub 2015 Feb 9.

23.

Clinical outcomes associated with evolving treatment modalities and radiation techniques for base-of-tongue carcinoma: thirty years of institutional experience.

Chen LA, Anker CJ, Hunt JP, Buchmann LO, Grossmann KF, Boucher K, Fang LM, Shrieve DC, Hitchcock YJ.

Cancer Med. 2015 May;4(5):651-60. doi: 10.1002/cam4.364. Epub 2015 Jan 26.

24.

The Prognostic Significance of Facial Nerve Involvement in Carcinomas of the Parotid Gland.

Terakedis BE, Hunt JP, Buchmann LO, Avizonis VN, Anker CJ, Hitchcock YJ.

Am J Clin Oncol. 2017 Jun;40(3):323-328. doi: 10.1097/COC.0000000000000157.

PMID:
25503431
25.

Early radiotherapy has an essential role for improving survival in patients with stage I-II nasal-type of NK/T cell lymphoma treated with L-asparaginase-containing chemotherapy--a single institution experience.

Zang J, Li C, Luo SQ, Wang JH, Xu M, Zhao LN, Li WW, Yang H, Xiao F, Hitchcock YJ, Shi M.

Ann Hematol. 2015 Apr;94(4):583-91. doi: 10.1007/s00277-014-2244-4. Epub 2014 Nov 21.

PMID:
25409913
26.

Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology.

Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Schuller DE, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2014 Oct;12(10):1454-87.

27.

RTOG 0631 phase 2/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: phase 2 results.

Ryu S, Pugh SL, Gerszten PC, Yin FF, Timmerman RD, Hitchcock YJ, Movsas B, Kanner AA, Berk LB, Followill DS, Kachnic LA.

Pract Radiat Oncol. 2014 Mar-Apr;4(2):76-81. doi: 10.1016/j.prro.2013.05.001. Epub 2013 Jun 4.

28.

Patterns of failure and predictors of outcome in cutaneous malignant melanoma of the scalp.

Terakedis BE, Anker CJ, Leachman SA, Andtbacka RH, Bowen GM, Sause WT, Grossmann KF, Bowles TL, Noyes RD, Hitchcock YJ, Boucher KM, Shrieve DC.

J Am Acad Dermatol. 2014 Mar;70(3):435-42. doi: 10.1016/j.jaad.2013.10.028. Epub 2013 Dec 24.

PMID:
24373782
29.

Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines.

Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Schuller DE, Shah JP, Spencer S, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2013 Aug;11(8):917-23. Erratum in: J Natl Compr Canc Netw. 2013 Dec 1;11(12):1458.

PMID:
23946171
30.

In Reply to O'Sullivan etĀ al.

Wang D, Bosch W, Roberge D, Finkelstein SE, Petersen I, Haddock M, Chen YL, Delaney TF, Saito NG, Kirsch DG, Hitchcock YJ, Wolfson AH.

Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):307-8. doi: 10.1016/j.ijrobp.2012.05.038. No abstract available.

PMID:
22935393
31.

Determination of cytokine protein levels in oral secretions in patients undergoing radiotherapy for head and neck malignancies.

Citrin DE, Hitchcock YJ, Chung EJ, Frandsen J, Urick ME, Shield W, Gaffney D.

Radiat Oncol. 2012 Apr 26;7:64. doi: 10.1186/1748-717X-7-64.

32.

Dosimetric evaluation of a "virtual" image-guidance alternative to explicit 6 degree of freedom robotic couch correction.

Sarkar V, Wang B, Hinkle J, Gonzalez VJ, Hitchcock YJ, Rassiah-Szegedi P, Joshi S, Salter BJ.

Pract Radiat Oncol. 2012 Apr-Jun;2(2):122-37. doi: 10.1016/j.prro.2011.07.005. Epub 2011 Sep 25.

PMID:
24674088
33.

Mucosal melanoma of the head and neck.

Pfister DG, Ang KK, Brizel DM, Burtness B, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Sanguineti G, Schuller DE, Shah JP, Spencer S, Trotti A 3rd, Weber RS, Wolf G, Worden F; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2012 Mar;10(3):320-38. No abstract available.

PMID:
22393194
34.

RTOG 0631 Phase II/III Study of Image-Guided Stereotactic Radiosurgery for Localized (1-3) Spine Metastases: Phase II Results.

Ryu S, Pugh SL, Gerszten PC, Yin FF, Timmerman RD, Hitchcock YJ, Movsas B, Kanner AA, Berk LB, Followill DS, Kachnic LA.

Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):S131-S132.

PMID:
23864755
35.

RTOG sarcoma radiation oncologists reach consensus on gross tumor volume and clinical target volume on computed tomographic images for preoperative radiotherapy of primary soft tissue sarcoma of extremity in Radiation Therapy Oncology Group studies.

Wang D, Bosch W, Roberge D, Finkelstein SE, Petersen I, Haddock M, Chen YL, Saito NG, Kirsch DG, Hitchcock YJ, Wolfson AH, DeLaney TF.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e525-8. doi: 10.1016/j.ijrobp.2011.04.038. Epub 2011 Jun 15.

36.

Head and neck cancers.

Pfister DG, Ang KK, Brizel DM, Burtness BA, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Sanguineti G, Schuller DE, Shah JP, Spencer S, Trotti A 3rd, Weber RS, Wolf GT, Worden F; National Comprehensive Concer Network.

J Natl Compr Canc Netw. 2011 Jun 1;9(6):596-650. Review. No abstract available. Erratum in: J Natl Compr Canc Netw. 2011 Jul;9(7):xxxiii.

PMID:
21636536
37.

Variation in the gross tumor volume and clinical target volume for preoperative radiotherapy of primary large high-grade soft tissue sarcoma of the extremity among RTOG sarcoma radiation oncologists.

Wang D, Bosch W, Kirsch DG, Al Lozi R, El Naqa I, Roberge D, Finkelstein SE, Petersen I, Haddock M, Chen YL, Saito NG, Hitchcock YJ, Wolfson AH, DeLaney TF.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e775-80. doi: 10.1016/j.ijrobp.2010.11.033. Epub 2011 Jan 27.

38.

IMRT with simultaneous integrated boost and concurrent chemotherapy for locoregionally advanced squamous cell carcinoma of the head and neck.

Montejo ME, Shrieve DC, Bentz BG, Hunt JP, Buchman LO, Agarwal N, Hitchcock YJ.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e845-52. doi: 10.1016/j.ijrobp.2010.10.021. Epub 2010 Dec 16.

PMID:
21167654
39.

Preoperative versus postoperative radiotherapy in soft-tissue sarcoma: multi-institutional analysis of 821 patients.

Sampath S, Schultheiss TE, Hitchcock YJ, Randall RL, Shrieve DC, Wong JY.

Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):498-505. doi: 10.1016/j.ijrobp.2010.06.034. Epub 2010 Oct 1.

PMID:
20888702
40.

Overall and cause-specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer.

Barney BM, Hitchcock YJ, Sharma P, Shrieve DC, Tward JD.

Head Neck. 2011 May;33(5):645-9. doi: 10.1002/hed.21504. Epub 2010 Aug 4.

PMID:
20687168
41.

Evaluation of fluence-smoothing feature for three IMRT planning systems.

Anker CJ, Wang B, Tobler M, Chapek J, Shrieve DC, Hitchcock YJ, Salter BJ.

J Appl Clin Med Phys. 2010 Apr 16;11(2):3035.

42.

Radiotherapy and extent of surgical resection in retroperitoneal soft-tissue sarcoma: multi-institutional analysis of 261 patients.

Sampath S, Hitchcock YJ, Shrieve DC, Randall RL, Schultheiss TE, Wong JY.

J Surg Oncol. 2010 Apr 1;101(5):345-50. doi: 10.1002/jso.21474.

PMID:
20119974
43.

Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.

Rodrigues RS, Bozza FA, Christian PE, Hoffman JM, Butterfield RI, Christensen CR, Heilbrun M, Wiggins RH 3rd, Hunt JP, Bentz BG, Hitchcock YJ, Morton KA.

J Nucl Med. 2009 Aug;50(8):1205-13. doi: 10.2967/jnumed.109.062075. Epub 2009 Jul 17.

44.

Surgery and radiotherapy improves survival in patients with anaplastic thyroid carcinoma: analysis of the surveillance, epidemiology, and end results 1983-2002.

Chen J, Tward JD, Shrieve DC, Hitchcock YJ.

Am J Clin Oncol. 2008 Oct;31(5):460-4. doi: 10.1097/COC.0b013e31816a61f3.

PMID:
18838882
45.

Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.

Hitchcock YJ, Tward JD, Szabo A, Bentz BG, Shrieve DC.

Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):779-88. doi: 10.1016/j.ijrobp.2008.05.040. Epub 2008 Aug 15.

PMID:
18707819
46.

The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer.

Brown AP, Chen J, Hitchcock YJ, Szabo A, Shrieve DC, Tward JD.

J Clin Endocrinol Metab. 2008 Feb;93(2):504-15. Epub 2007 Nov 20.

PMID:
18029468
47.

Planned neck dissection after definitive radiotherapy or chemoradiation for base of tongue cancers.

Hitchcock YJ, Bentz BG, Sharma PK, Fang C, Tward JD, Pappas L, Chen J, Hayes JK, Shrieve DC.

Otolaryngol Head Neck Surg. 2007 Sep;137(3):422-7.

PMID:
17765769
48.

Treatment of oropharyngeal squamous cell carcinoma with external beam radiation combined with interstitial brachytherapy.

Chen J, Pappas L, Moeller JH, Rankin J, Sharma PK, Bentz BG, Fang LC, Hayes JK, Shrieve DC, Hitchcock YJ.

Head Neck. 2007 Apr;29(4):362-9.

PMID:
17163468
49.

Contrast-enhanced MRI for the assessment of local recurrence after breast conservation.

Hitchcock YJ, Proulx GM, Stomper PC.

Am J Clin Oncol. 2002 Aug;25(4):428-9. No abstract available.

PMID:
12151979

Supplemental Content

Loading ...
Support Center